| scholarly article | Q13442814 |
| P50 | author | Donald M Thea | Q39024816 |
| Nancy Scott | Q47804756 | ||
| Louise Kuhn | Q61451544 | ||
| Chipepo Kankasa | Q81697874 | ||
| Moses Sinkala | Q90798004 | ||
| Grace M Aldrovandi | Q91365746 | ||
| P2093 | author name string | Jan Walter | |
| Mwiya Mwiya | |||
| Prisca Kasonde | |||
| Shuaib Kauchali | |||
| P2860 | cites work | Antibiotics for treating bacterial vaginosis in pregnancy | Q24244988 |
| Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality | Q30879958 | ||
| Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal | Q32165540 | ||
| Adverse reactions to trimethoprim-sulfamethoxazole | Q33484021 | ||
| Antibiotics for asymptomatic bacteriuria in pregnancy. | Q33907153 | ||
| Folic acid antagonists during pregnancy and the risk of birth defects. | Q33926560 | ||
| The burden of malaria in pregnancy in malaria-endemic areas. | Q34292893 | ||
| Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda | Q34359439 | ||
| Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial | Q34369756 | ||
| Neonatal sepsis: an international perspective | Q35296703 | ||
| 15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery | Q35530020 | ||
| Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial | Q36245577 | ||
| Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings | Q36493593 | ||
| Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi | Q37055187 | ||
| Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa | Q37247058 | ||
| Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda | Q37873041 | ||
| Maternal human immunodeficiency virus-1 infection and pregnancy outcome | Q37889154 | ||
| The contribution of low birth weight to infant mortality and childhood morbidity | Q39813190 | ||
| Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth. | Q43471616 | ||
| Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya | Q43556077 | ||
| The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study | Q43819085 | ||
| Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
| Association between low birth weight and infant mortality in children born to human immunodeficiency virus 1-infected mothers in Tanzania | Q43948726 | ||
| Determinants of low birth weight among HIV-infected pregnant women in Tanzania | Q43950680 | ||
| Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study | Q45008686 | ||
| Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission | Q45421103 | ||
| Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe | Q46348110 | ||
| The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. | Q46357603 | ||
| Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? | Q46373144 | ||
| The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth | Q46979464 | ||
| The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya | Q47923816 | ||
| Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. | Q51712814 | ||
| Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa | Q59689434 | ||
| Voluntary counselling, HIV testing and sexual behaviour among patients with tuberculosis in a rural district of Malawi | Q62488580 | ||
| Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial | Q64131962 | ||
| Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS | Q68090731 | ||
| The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network | Q71552569 | ||
| Impact of maternal HIV‐1 infection on perinatal outcome | Q71994847 | ||
| Urinary tract infections in pregnancy | Q73372537 | ||
| Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study | Q74523703 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1510-1518 | |
| P577 | publication date | 2006-10-19 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts | |
| P478 | volume | 194 |
| Q53679268 | A man with unsuspected marine eosinophilic gastritis. |
| Q28076750 | Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? |
| Q33926897 | Cotrimoxazole and neonatal kernicterus: a review |
| Q33474822 | Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease |
| Q42249162 | Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial |
| Q36960424 | Effects of early, abrupt weaning on HIV-free survival of children in Zambia |
| Q33587760 | Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers |
| Q38436157 | Embracing a family-centred response to the HIV/AIDS epidemic for the elimination of pediatric AIDS. |
| Q36020074 | HIV-1 concentrations in human breast milk before and after weaning |
| Q33312382 | High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission |
| Q35689226 | Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations |
| Q38261803 | Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach |
| Q28387497 | Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi |
| Q36980850 | New approaches to pathogenesis of malaria in pregnancy. |
| Q34399972 | Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women |
| Q43642435 | Preventing malaria in HIV-infected pregnant women |
| Q34500949 | Prevention of mother to child transmission of human immunodeficiency virus: the nigerian perspective |
| Q33396553 | Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study |
| Q35551457 | Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy |
| Q21133667 | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review |
| Q36834927 | Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment |
| Q35090697 | Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis |
| Q28538874 | Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial |
| Q37185959 | Successful completion of pregnancy in a woman with chronic granulomatous disease |
| Q37378079 | The HIV-exposed, uninfected African child |
| Q37398249 | The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women |
| Q38330997 | The expanding role of co-trimoxazole in developing countries |
| Q37640105 | Urinary Tract Infections among HIV-Positive Pregnant Women in Mwanza City, Tanzania, Are High and Predicted by Low CD4+ Count |
Search more.